Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 10261-82-2 | MDL No. : | MFCD10574724 |
Formula : | C8H6N2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OJFSCKNLUYOABN-UHFFFAOYSA-N |
M.W : | 146.15 | Pubchem ID : | 589680 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 42.36 |
TPSA : | 45.75 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.98 cm/s |
Log Po/w (iLOGP) : | 1.25 |
Log Po/w (XLOGP3) : | 0.3 |
Log Po/w (WLOGP) : | 0.92 |
Log Po/w (MLOGP) : | 0.72 |
Log Po/w (SILICOS-IT) : | 2.12 |
Consensus Log Po/w : | 1.06 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.61 |
Solubility : | 3.61 mg/ml ; 0.0247 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.82 |
Solubility : | 22.0 mg/ml ; 0.15 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.21 |
Solubility : | 0.0895 mg/ml ; 0.000612 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.7 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1.08 g | at 100℃; for 3 h; | A 250 mL round bottomed flask charged with 1,5-naphthyridin-2(1H)-one (2.98 g, 20.37 mmol) and phosphorus oxychloride (40 ml, 437 mmol) was heated at 100° C. for 3 h. The reaction was cooled to room temperature and excess POCl3 was removed in vacuo. The residue was poured onto ice and neutralized with NaHCO3. The mixture was extracted with DCM (4*) and the combined organic layers were evaporated onto silica gel and purified by flash chromatography (ISCO (80 gram)) eluting with EtOAc:DCM (0:1→1:4) to give 1.08 g (32percent, 2 steps) of a light-yellow amorphous solid. ESI-MS 164.9, 166.9 [M+1]. |
2.86 g | at 100℃; for 5 h; | To the compound 0001-1 (2.76 g), phosphorous oxychloride (8.3 mL) was added, and the mixture was stirred at 100°C for 5 hours. The reaction solution which had been cooled to room temperature was added dropwise to a mixture of ethyl acetate (30 mL), water (30 mL), and sodium carbonate (9.57 g) in an ice-cooling bath over one hour. Further, water (10 mL) was added thereto, and sodium carbonate was added thereto until the pH reached 8.3. After stirring at room temperature for 10 minutes, the resulting mixture was subjected to liquid separation by the addition of ethyl acetate (270 mL) and water (200 mL). Further, the aqueous layer was extracted with ethyl acetate (200 mL) twice. The collected organic layer was dried over sodium sulfate and the solvent was evaporated under reduced pressure to obtain a compound 0001-2 (2.86 g) was obtained as a pale yellow solid. 1H-NMR (DMSO-d6) δ: 9.05 (1H, dd), 8.50 (1H, dd, J=8.9), 8.41 (1H, ddd), 7.87, (1H, d), 7.86 (1H, m). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
2.86 g | at 100℃; for 5 h; | 0001-2 Phosphorus oxychloride (8.3 mL) was added to 1,5-naphthyridin-2-ol (2.76 g), followed by stirring at 100° C. for 5 hours. The reaction mixture was cooled to room temperature, and added dropwise to a mixture of ethyl acetate (30 mL), water (30 mL), and sodium carbonate (9.57 g) over a period of 1 hour in an ice bath. Water (10 mL) was added thereto, and sodium carbonate was added thereto, followed by adjusting the pH of the resultant product to 8.3. The resultant product was stirred at room temperature for 10 minutes, and ethyl acetate (270 mL) and water (200 mL) were added thereto. The organic layer was collected by separation, and the aqueous layer was extracted two times with ethyl acetate (200 mL). The organic layer and the extraction liquid were combined, the resultant product was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure, thereby obtaining 2-chloro-1,5-naphthyridine (2.86 g) as a pale yellow solid. MS m/z (M+H): 165. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98% | at 110℃; for 2 h; | Intermediate 2 (15.8 g) was stirred in 6N HCl (100 ml) at 110°C for 2h. The mixture was cooled at 0°C and the pH was adjusted to 6-7 with solid NaOH. The precipitated solid was isolated by filtration with suction, dried on the sinter with suction for 2h, and dried in a vacuum at 45°C to give the desired (14.4 g, 98percent). [ES MS] m/z 147 (MH+). |
98% | Stage #1: With hydrogenchloride In water at 110℃; for 2 h; Stage #2: With sodium hydroxide In water at 0℃; |
Intermediate 2 (15.8 g) was stirred in 6N HCI (100 ml) at 11 O0C for 2h. The mixture was cooled at O0C and the pH was adjusted to 6-7 with solid NaOH. The precipitated solid was isolated by filtration with suction, dried on the sinter with suction for 2h, and dried in a vacuum at 450C to give the desired (14.4 g, 98percent). [ES MS] m/z 147 (MH+). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
2.51 g | With bis(tri-t-butylphosphine)palladium(0); triethylamine In cyclohexyl acetate at 150℃; for 40 h; Inert atmosphere | Triethylamine (13 mL), butyl acrylate (10 mL), and bis(tritert-butylphosphine)palladium (0) (350 mg) were added to a solution of 2-chloro-3-aminopyridine (6.00 g) in cyclohexyl acetate (60 mL), and the mixture was stirred at 150°C for 40 hours under a nitrogen atmosphere. The resulting mixture was left to be cooled at room temperature. When the mixture was cooled to 70°C, water (30 mL) was added thereto, and the resulting mixture was left to be cooled at room temperature under stirring. After subjecting the resulting mixture to sonication for 30 minutes, the mixture was filtered and the residue was washed with water (3 mL). The obtained residue was suspended in ethyl acetate (3 mL)/2-propanol (4 mL) and then subjected to sonication. Further, the suspension was filtered, and the residue was washed with ethyl acetate (3 mL) and hexane, and thereafter is dried to obtain a compound 0001-1 (2.51 g) as a pale yellow solid. 1H-NMR (DMSO-d6) δ: 11.90 (1H, s), 8.47 (1H, dd), 7.93 (1H, d), 7.68 (1H, ddd), 7.51 (1H, dd), 6.75 (1H, dd). MS m/z (M+H): 147. |
[ 76102-92-6 ]
2-Amino-N-(pyridin-3-yl)benzamide
Similarity: 0.82
[ 32501-05-6 ]
1H-Pyrrolo[3,2-b]pyridin-2(3H)-one
Similarity: 0.74
[ 1628557-05-0 ]
N-(5-Cyano-2-methylpyridin-3-yl)acetamide
Similarity: 0.73
[ 301666-63-7 ]
6,7-Dihydro-1,7-naphthyridin-8(5H)-one
Similarity: 0.64